Friday, November 22, 2024

TOPIC

covaxin

US govt’s primary health research institute NIH says Covaxin is highly effective against Alpha and Delta variants of Covid-19

NIH report says that Covaxin generates antibodies that effectively neutralise the Alpha and Delta variants of Sars-CoV-2

India secures milestone in Coronavirus vaccination drive, administers over 86 lakh doses in a single day: Details

CoWIN app showed that Madhya Pradesh administered a whopping 13,71,180 lakh vaccine doses alone on Monday.

Congress leader spreads vaccine hesitancy again, this time claims newborn calves are slaughtered for their serum. Here is the truth

Covaxin does not contain newborn calf serum. It was used for development of cells to replicate Covid-19 virus in lab to produce vaccine.

US FDA rejects emergency use application for Bharat Biotech’s Covaxin, asks Ocugen to launch additional trial for full approval

The US FDA had asked Ocugen to pursue BLA submission and not Emergency Use Approval(EUA), paving the way for the vaccine's full approval in the United States.

After fanning vaccine hesitancy, The Print blames Telegram, Instagram and Central Govt for growth of anti-vaxxer groups

ThePrint is now blaming groups on Telegram and Instagram for spreading anti-vaxxer rumours among people.

Petition wants Delhi High Court to cancel Center’s approval for Covaxin to conduct trials for 2-18 age group

The petitioner wants Delhi High Court to quash govt notification allowing Covaxin trials for the 2-18 age group.

Chhattisgarh health minister who had spread vaccine hesitancy against Bharat Biotech’s Covaxin now takes the same jab

Chhattisgarh health minister T S Singh Deo, who proudly took to Twitter to flaunt his first jab of Covaxin had indulged in fear-mongering against the same vaccine earlier, spreading vaccine hesitancy and fear among the people.

Bharat Biotech welcomes other pharma companies to manufacture Covaxin, but only one other Indian company has the required facility

Only 2 Indian companies have BSL3 level plants to produce Covaxin made from inactivated virus, Bharat Biotech and Panacea Biotec

Bombay HC orders Maharashtra govt to approve transfer of vaccine plant to Bharat Biotech after forest dept blocked the deal

Biovet has purchased the vaccine plant from its previous owner, but Maharashtra forest department was not allowing the transfer

Bharat Biotech’s Covaxin gets a nod for phase 2 and 3 trials on 2-18 years-olds

SEC allows Phase 2 and Phase human clinical trials for Bharat Biotech's Covaxin for children between 2 to 18 years

Latest News

Recently Popular